Physician profile
Beverly Mossman
NPI 1093750333
$3,304.80
in general payments reported to CMS, 2019-2025
12 companies · $579 in 2025
The $579 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $641 · 2021: $327 · 2022: $378 · 2023: $408 · 2024: $655 · 2025: $579.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,641.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,177.14 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $643.32 | 2019-2025 | Jardiance, Stiolto Respimat |
| Glaxosmithkline, LLC. | $592.01 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $236.08 | 2020-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $183.18 | 2019-2024 | |
| Esperion Therapeutics, INC. | $147.73 | 2020 | |
| Boston Scientific Corporation | $102.59 | 2019 | |
| Novo Nordisk INC | $91.13 | 2020-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $57.18 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.84 | 2019 | |
| Medtronic USA, INC. | $25.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Mossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.